ArticleMolecular biology reports2025
A diagnostic target in the 3' untranslated region of hepatitis C virus genome.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHepatitis C virus (HCV) causes hepatitis worldwide. Detection of HCV infection is important for diagnosis and treatment. The most frequently used method for diagnosis is the detection of the 5' untranslated (5' UTR) conserved target using polymerase chain reaction (PCR). Unfortunately, the detection of the 5'UTR is not completely reliable. The 5'UTR may not be the best target for nucleic acid detection because of its complex secondary structures and the variations of different HCV strains. An alternative target is the 3'UTR. The purpose is to evaluate the diagnostic potential of the 3'UTR of HCV. METHODS AND
resultsRNA was extracted from sixty-three serum samples. The 3'UTR and 5'UTR were amplified. Within the fifty-nine anti-HCV-positive samples, targeting the HCV 3'UTR and 5'UTR resulted in amplification in 40 (67.8%) and 54 (91.5%) of the samples, respectively. Five samples that were not amplified by 5'UTR detection were found positive by 3'UTR detection.
conclusionThese results indicate that PCR detection of the HCV 3'UTR appears less effective than detection of the 5'UTR. Nevertheless, the detection of several regions of the HCV genome by multiplex PCR may improve the accuracy of HCV detection.
Indexed as
Identifiers
40192839What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.